Efficacy and safety in the continued treatment with a biosimilar drug in patients receiving Infliximab: use of a systematic review in the context of decision making from a Latin-American country

Edward Mezones-Holguin, Rocio Violeta Gamboa-Cardenas, Gadwyn Sanchez-Felix, José Chávez-Corrales, Luis Miguel Helguero-Santin, L Max Laban-Seminario, Paula Alejandra Burela-Prado, Maribel Marilu Castro-Reyes, Fabian Fiestas

Resultado de la investigación: Contribución a una revistaArtículo de revisiónInvestigaciónrevisión exhaustiva

Idioma originalInglés estadounidense
PublicaciónFrontiers in Pharmacology
Volumen10
EstadoPublicada - 8 sep 2019

Citar esto

Mezones-Holguin, Edward ; Gamboa-Cardenas, Rocio Violeta ; Sanchez-Felix, Gadwyn ; Chávez-Corrales, José ; Helguero-Santin, Luis Miguel ; Laban-Seminario, L Max ; Burela-Prado, Paula Alejandra ; Castro-Reyes, Maribel Marilu ; Fiestas, Fabian. / Efficacy and safety in the continued treatment with a biosimilar drug in patients receiving Infliximab: use of a systematic review in the context of decision making from a Latin-American country. En: Frontiers in Pharmacology. 2019 ; Vol. 10.
@article{e8ae6965e0bb4843807f91aa718eed56,
title = "Efficacy and safety in the continued treatment with a biosimilar drug in patients receiving Infliximab: use of a systematic review in the context of decision making from a Latin-American country",
author = "Edward Mezones-Holguin and Gamboa-Cardenas, {Rocio Violeta} and Gadwyn Sanchez-Felix and Jos{\'e} Ch{\'a}vez-Corrales and Helguero-Santin, {Luis Miguel} and Laban-Seminario, {L Max} and Burela-Prado, {Paula Alejandra} and Castro-Reyes, {Maribel Marilu} and Fabian Fiestas",
year = "2019",
month = "9",
day = "8",
language = "American English",
volume = "10",
journal = "Frontiers in Pharmacology",
issn = "1663-9812",
publisher = "Frontiers Media",

}

Mezones-Holguin, E, Gamboa-Cardenas, RV, Sanchez-Felix, G, Chávez-Corrales, J, Helguero-Santin, LM, Laban-Seminario, LM, Burela-Prado, PA, Castro-Reyes, MM & Fiestas, F 2019, 'Efficacy and safety in the continued treatment with a biosimilar drug in patients receiving Infliximab: use of a systematic review in the context of decision making from a Latin-American country', Frontiers in Pharmacology, vol. 10.

Efficacy and safety in the continued treatment with a biosimilar drug in patients receiving Infliximab: use of a systematic review in the context of decision making from a Latin-American country. / Mezones-Holguin, Edward; Gamboa-Cardenas, Rocio Violeta; Sanchez-Felix, Gadwyn; Chávez-Corrales, José; Helguero-Santin, Luis Miguel; Laban-Seminario, L Max; Burela-Prado, Paula Alejandra; Castro-Reyes, Maribel Marilu; Fiestas, Fabian.

En: Frontiers in Pharmacology, Vol. 10, 08.09.2019.

Resultado de la investigación: Contribución a una revistaArtículo de revisiónInvestigaciónrevisión exhaustiva

TY - JOUR

T1 - Efficacy and safety in the continued treatment with a biosimilar drug in patients receiving Infliximab: use of a systematic review in the context of decision making from a Latin-American country

AU - Mezones-Holguin, Edward

AU - Gamboa-Cardenas, Rocio Violeta

AU - Sanchez-Felix, Gadwyn

AU - Chávez-Corrales, José

AU - Helguero-Santin, Luis Miguel

AU - Laban-Seminario, L Max

AU - Burela-Prado, Paula Alejandra

AU - Castro-Reyes, Maribel Marilu

AU - Fiestas, Fabian

PY - 2019/9/8

Y1 - 2019/9/8

M3 - Review article

VL - 10

JO - Frontiers in Pharmacology

JF - Frontiers in Pharmacology

SN - 1663-9812

ER -